CNS PHARMACEUTICALS INC (CNSP) Stock Cash Flow
NASDAQ:CNSP - Nasdaq - US18978H4092 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -15.61M | -14.86M | -18.85M | -15.27M | -14.04M | |||
| Depreciation Amortization | 4.40K | 3.30K | 4.10K | 10.00K | 10.00K | |||
| Change In Working Capital | -2.85M | -3.69M | 3.70M | 3.16M | -1.24M | |||
| Interest Paid | 9.80K | 13.60K | 13.80K | 10.00K | 10.00K | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 1.30M | 1.44M | 1.01M | 1.54M | 1.72M | |||
| OPERATING CASH FLOW | -17.17M | -17.11M | -14.14M | -10.56M | -13.54M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -4.20K | -3.90K | 0.00 | -10.00K | |||
| INVESTING CASH FLOW | N/A | -4.20K | -3.90K | 0.00 | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -297.70K | -300.80K | -438.70K | -430.00K | -480.00K | |||
| Stock Issued/Repurchased | 28.88M | 23.40M | 5.08M | 16.04M | 4.99M | |||
| Other Financing Activity | N/A | -66.80K | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 29.40M | 23.03M | 4.64M | 15.61M | 4.51M | |||
| CHANGE IN CASH | 12.23M | 5.91M | -9.51M | 5.05M | -9.04M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.17M | -17.11M | -14.14M | -10.56M | -13.54M | |||
| Capital Expenditure | N/A | -4.20K | -3.90K | 0.00 | -10.00K | |||
| FREE CASH FLOW | -17.17M | -17.12M | -14.14M | -10.56M | -13.55M | |||
All data in USD